The prevalence of obesity and diabetes mellitus (DM) has been consistently increasing
worldwide. Sharing powerful genetic and environmental features in their pathogenesis …

Evidence is accumulating that the gut microbiome is involved in the aetiology of obesity and
obesity-related complications such as nonalcoholic fatty liver disease (NAFLD), insulin …

The interplay of gut microbiota, host metabolism, and metabolic health has gained increased
attention. Gut microbiota may play a regulatory role in gastrointestinal health, substrate …

The cause of insulin resistance in obesity and type 2 diabetes mellitus (T2DM) is not limited
to impaired insulin signalling but also involves the complex interplay of multiple metabolic …

The connection between the gut microbiota and the aetiology of obesity and cardiometabolic
disorders is increasingly being recognized by clinicians. Our gut microbiota might affect the …

A poor diet is one of the leading causes for noncommunicable diseases. Due to the
increasing prevalence of overweight and obesity, there is a strong focus on dietary …

Accumulating evidence indicates that the gut microbiome is an important regulator of body
weight, glucose and lipid metabolism, and inflammatory processes, and may thereby play a …

Short-chain fatty acids (SCFAs), especially acetate, propionate and butyrate, are the end
products from the intestinal microbial fermentation of dietary fibers and resistant starch. It has …

Evidence is accumulating that short chain fatty acids (SCFA) play an important role in the
maintenance of gut and metabolic health. The SCFA acetate, propionate and butyrate are …

Gestational diabetes mellitus (GDM) is defined as impaired glucose tolerance recognized
during pregnancy. GDM is associated with metabolic disorder phenotypes, such as obesity …